Abstract:Transcriptional enhancers function as nucleation sites for the assembly of transcription-regulating complexes across the genome, which act to drive cell type-specific patterns of gene expression. Although many features of active enhancers [e.g., H3K4me1, H3K27ac, enrichment of p300/CBP and Mediator, and production of enhancer RNAs (eRNAs)] have been defined by genomic assays, the roles of these features in estrogen receptor alpha (ERa) enhancer function are not well understood. We are interested in how the molecular underpinnings of ERa enhancer formation and activity control the gene expression programs that drive breast cancer phenotypes and responses to therapeutic agents. We have used a variety of molecular, biochemical, genomic, genetic, and computational approaches to determine the following aspects of ERa enhancers biology in hormone-responsive breast cancer cells: (1) where ERa enhancers are formed across the genome, (2) the kinetics of ERa enhancer formation and disassembly, (3) the influence of genetic variation on ERa enhancer function, (4) the role of the enhancer features noted above in ERa enhancer function, and (5) how protein complexes and small polypeptides serve as coregulators to drive ERa transcriptional activity. Our current focus has been on eRNAs, which are poorly characterized noncoding RNAs that are thought to regulate enhancer function and gene expression. We have identified a ~40 nucleotide functional eRNA regulatory motif (FERM) present in many estrogen-regulated eRNAs that promotes gene expression by increasing ERα recruitment and stimulating p300-catalyzed H3K27 acetylation. In addition, we have been examining how the dose of estrogen impacts the efficiency of enhancer assembly by ERα. Finally, we have been exploring the role of PARP1, a ubiquitous chromatin-associated regulator, and small polypeptides derived from "non-coding" RNAs, control ERa enhancer function. In all cases, we perform analyses to link enhancer function to gene expression outcomes and breast cancer biology. Collectively, our results demonstrate the biological and mechanistic roles of eRNAs in breast cancer. This work is supported by grants from the NIH/NIDDK (DK058110) and CPRIT (RP160319) to W.L.K. Citation Format: W. Lee Kraus. Molecular and genomic mechanisms of estrogen signaling and gene regulation in breast cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1) nr IA13.

Epigenetic factors that control estrogen receptor alpha (ERα) binding site utilization and specificity in the MCF-7 human breast cancer cell line

Epigenomics-based Identification of Oestrogen-Regulated Long Noncoding RNAs in ER+ Breast Cancer.

Mapping of the estrogen receptor: GATA-3 interactome in MCF-7 human mammary carcinoma cells

Identification and Functional Annotation of Genome-Wide ER-Regulated Genes in Breast Cancer Based on ChIP-Seq Data.

Whole-Genome Cartography of Estrogen Receptor Α Binding Sites

Abstract 5240: Functional and Therapeutic Significance of ESR1 Gene Fusions in Breast Cancer

ChIP-seq predicted estrogen receptor biding sites in human breast cancer cell line MCF7

Integrative Model of Genomic Factors for Determining Binding Site Selection by Estrogen Receptor‐α

Sensitive Chip-Dsl Technology Reveals An Extensive Estrogen Receptor Alpha-Binding Program On Human Gene Promoters

Sensitive ChIP-DSL technology reveals an extensive estrogen receptor α-binding program on human gene promoters

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators

Genome-wide Analysis Uncovers High Frequency, Strong Differential Chromosomal Interactions and Their Associated Epigenetic Patterns in E2-mediated Gene Regulation

Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells

A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

Integration of RNA-seq and Ribosome Profiling to Characterize Transcriptional and Translational Estrogen Responses of Genes in Human Breast Cancer

Abstract IA13: Molecular and genomic mechanisms of estrogen signaling and gene regulation in breast cancer

Estrogen receptor alpha (ERα) driven trans-regulation of mitotic checkpoint complex (MCC) components affects the clinical outcome of breast cancer

Quantitative proteomics of epigenetic histone modifications in MCF-7 cells under estradiol stimulation

Research Resource: Whole-Genome Estrogen Receptor Alpha Binding In Mouse Uterine Tissue Revealed By Chip-Seq

Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase